Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
164.3 USD | +0.33% | +2.45% | +6.04% |
May. 15 | Transcript : AbbVie Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:40 AM | |
May. 15 | Medincell: share price falls after disappointing clinical study | CF |
Financials (USD)
Sales 2024 * | 55.14B | Sales 2025 * | 58.11B | Capitalization | 289B |
---|---|---|---|---|---|
Net income 2024 * | 7.74B | Net income 2025 * | 10.64B | EV / Sales 2024 * | 6.22 x |
Net Debt 2024 * | 53.62B | Net Debt 2025 * | 47.29B | EV / Sales 2025 * | 5.79 x |
P/E ratio 2024 * |
31.9
x | P/E ratio 2025 * |
24.5
x | Employees | 50,000 |
Yield 2024 * |
3.77% | Yield 2025 * |
3.96% | Free-Float | 96.37% |
Latest transcript on AbbVie Inc.
1 day | +0.33% | ||
1 week | +2.42% | ||
Current month | +1.04% | ||
1 month | +1.65% | ||
3 months | -6.94% | ||
6 months | +19.43% | ||
Current year | +6.04% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 12-12-31 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 12-12-31 |
Robert Michael
PSD | President | 53 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 63 | 12-12-31 |
Edward Rapp
BRD | Director/Board Member | 66 | 12-12-31 |
Director/Board Member | 70 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.12% | 6 M€ | +7.34% | - | |
6.85% | 17 M€ | +7.35% | - | |
6.26% | 13 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 164.4 | +0.34% | 4,642,038 |
24-05-15 | 163.8 | +1.36% | 5,261,263 |
24-05-14 | 161.6 | +0.19% | 4,025,032 |
24-05-13 | 161.3 | +0.33% | 3,505,882 |
24-05-10 | 160.8 | +0.22% | 3,509,603 |
Delayed Quote Nyse, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.04% | 289B | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B | |
+0.45% | 163B |
- Stock Market
- Equities
- ABBV Stock